Monroe, Tanner O. http://orcid.org/0000-0001-9117-2227
Garrett, Melanie E.
Kousi, Maria
Rodriguiz, Ramona M.
Moon, Sungjin
Bai, Yushi
Brodar, Steven C.
Soldano, Karen L.
Savage, Jeremiah
Hansen, Thomas F.
Muzny, Donna M.
Gibbs, Richard A.
Barak, Lawrence
Sullivan, Patrick F.
Ashley-Koch, Allison E. http://orcid.org/0000-0001-5409-9155
Sawa, Akira http://orcid.org/0000-0003-1401-3008
Wetsel, William C. http://orcid.org/0000-0002-3592-7397
Werge, Thomas http://orcid.org/0000-0003-1829-0766
Katsanis, Nicholas http://orcid.org/0000-0002-2480-0171
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Information Technology (P30-CA060553)
U.S. Department of Health & Human Services | National Institutes of Health (P41 EB015897, 5T32DK108738-04, U54 HG002373, MH084018)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 24 November 2017
Accepted: 13 October 2020
First Online: 19 November 2020
Competing interests
: N.K. holds significant stock in Rescindo Therapeutics. The remaining co-authors declare no competing interests.